Phase 1 Clinical Trials

Phase 1 Clinical Trials & Beyond

  • Clinical pharmacology, Phases 1a and 1b
  • Early efficacy, Phase 2a
  • Pharmacokinetic profiling
  • Proof of Concept (POC)
  • Maximum tolerated dose
  • Drug/drug interaction
  • Bioavailability/bioequivalence, including single dose, multiple dose and food effect
  • Normal healthy, specialized and/or disease-state populations

Learn more about HRIPT, cumulative irritation, photoxicity and photoallergy/photosensitization studies within our  Phase 1 Dermatology Clinical Trials services.